Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)

China flag China · Delayed Price · Currency is CNY
3.670
-0.140 (-3.67%)
May 21, 2026, 3:00 PM CST
Market Cap2.88B +2.5%
Revenue (ttm)1.72B -18.2%
Net Income-349.70M
EPS-0.45
Shares Out784.39M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume26,974,985
Average Volume52,527,799
Open3.810
Previous Close3.810
Day's Range3.640 - 3.850
52-Week Range3.440 - 5.270
Beta0.26
RSI34.47
Earnings DateApr 23, 2026

About SHA:600594

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, analgesic, cancer, orthopedics, digestion, andrology, and urology. The company also engages in investme... [Read more]

Sector Healthcare
Founded 1995
Employees 5,261
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600594
Full Company Profile

Financial Performance

In 2025, SHA:600594's revenue was 1.86 billion, a decrease of -14.31% compared to the previous year's 2.17 billion. Losses were -329.56 million, 3.89% more than in 2024.

Financial Statements